日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells

吉西他滨调节 HLA-I 调控以改善胰腺癌细胞的肿瘤抗原呈递

Alaina C Larson, Shelby M Knoche, Gabrielle L Brumfield, Kenadie R Doty, Benjamin D Gephart, Promise R Moore-Saufley, Joyce C Solheim

Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor

胰腺癌细胞中主要组织相容性复合体 I 类分子的表达受表皮生长因子受体的激活和抑制调控

Shelby M Knoche, Alaina C Larson, Gabrielle L Brumfield, Steven Cate, William H Hildebrand, Joyce C Solheim

The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer

组蛋白去乙酰化酶抑制剂 M344 作为胰腺癌的多方面治疗方法

Shelby M Knoche, Gabrielle L Brumfield, Benjamin T Goetz, Bailee H Sliker, Alaina C Larson, Madeline T Olson, Brittany J Poelaert, Audrey Bavari, Ying Yan, Jennifer D Black, Joyce C Solheim

Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer

淀粉样前体样蛋白 2 表达在胰腺癌发展过程中增加并缩短自发性胰腺癌小鼠模型的生存期

Brittany J Poelaert, Shelby M Knoche, Alaina C Larson, Poomy Pandey, Parthasarathy Seshacharyulu, Nuzhat Khan, H Carlo Maurer, Kenneth P Olive, Yuri Sheinin, Rizwan Ahmad, Amar B Singh, Surinder K Batra, Satyanarayana Rachagani, Joyce C Solheim